Name:
Serratia grimesii Grimont et al. 1983
DSM No.:
30063, Type strain dsm-30063 dsm30063 dsm 30063 Serratia grimesii
Other collection no.
or WDCM no.:
ATCC 14460,IFO 13537,NCTC 10422,NBRC 13537,JCM 31911
Country:
country of origin unknown
Date of sampling:
before 22.08.1990
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- ATCC <- R.E. Buchanan (Enterobacter liquefaciens) <- M. Grimes (Aerobacter lipolyticus). Grimont 503
Summary and
additional information:
<- ATCC <- R.E. Buchanan (Enterobacter liquefaciens) <- M. Grimes (Aerobacter lipolyticus). Grimont 503. Type strain. Taxonomy/description (2494, 3031, 3123, 12641). Produces L-carnitine (U.S. Pat. 4,650,759). (Medium 1, 30°C)
Risk group:
2 (classification according to German
TRBA)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz),
Category A1
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 100,- € |
| Active culture on request | | 240,- € |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.Note: Freight charges for Risk Group 2 microorganisms will apply.
